DANA Inc (DAN) stock
Close on Nov 12, 2026Market cap $2.50BP/E 2.4Yield 1.72%
Earnings
DANA's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of DANA's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 17, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026before the open | $2.04B | +6.3% | $0.14 | $0.41 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026before the open | $2.01B | +3.1% | – | $0.19 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026before the open | $1.87B | -20.4% | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 18, 2026before the open | $1.90B | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 29, 2025before the open | $1.92B | -22.6% | $0.07 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025before the open | $1.95B | -28.8% | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 30, 2025before the open | $2.35B | -14.2% | $0.17 | $0.13 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 24, 2025before the open | – | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 30, 2024before the open | $2.48B | -7.1% | $0.03 | $0.12 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 31, 2024before the open | $2.74B | -0.4% | $0.11 | $0.31 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 30, 2024before the open | $2.74B | +3.8% | $0.02 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 20, 2024before the open | $2.50B | -2.3% | -$0.27 | -$0.08 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 27, 2023before the open | $2.67B | +5.1% | $0.13 | $0.30 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 28, 2023before the open | $2.75B | +6.2% | $0.21 | $0.37 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 28, 2023before the open | $2.64B | +6.5% | $0.19 | $0.25 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 21, 2023before the open | $2.56B | +12.8% | -$1.25 | -$0.10 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 27, 2022before the open | $2.54B | +15.5% | -$0.61 | $0.24 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 3, 2022before the open | $2.59B | – | $0.06 | $0.08 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 27, 2022before the open | $2.48B | – | $0.12 | $0.16 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 23, 2022before the open | $2.27B | – | $0.18 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 26, 2021before the open | $2.20B | – | $0.33 | $0.41 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 5, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 28, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 18, 2021before the open | – | – | – | – | Release |
| Q3 FY2020ended Sep 30, 2020 | Oct 28, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
DANA's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| SalesGAAP | FY2026 | $7.75B – $7.85B | – | New | Oct 28, 2026 |
| Sales | FY2026 | $7.30B – $7.70B | $7.30B – $7.70B | Reaffirmed | Apr 29, 2026 |
| Adjusted EBITDA marginsnon-GAAP | FY2026 | 10% – 10.5% | – | New | Aug 5, 2025 |
| Implied adjusted EBITDA marginnon-GAAP | FY2026 | 10% – 11% | 10% – 11% | Reaffirmed | Apr 29, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $800.00M – $850.00M | – | New | Oct 28, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $750.00M – $850.00M | $750.00M – $850.00M | Reaffirmed | Apr 29, 2026 |
| Diluted Adjusted EPSnon-GAAP | FY2026 | $1.75 – $2.25 | – | New | Oct 28, 2026 |
| Diluted Adjusted EPSnon-GAAP | FY2026 | $2.00 – $3.00 | $2.00 – $3.00 | Reaffirmed | Apr 29, 2026 |
| Adjusted free cash flownon-GAAP | FY2026 | $275.00M – $375.00M | – | New | Oct 28, 2026 |
| Adjusted free cash flownon-GAAP | FY2026 | $250.00M – $350.00M | $250.00M – $350.00M | Reaffirmed | Apr 29, 2026 |
| Adjusted free cash flownon-GAAP | FY2026 | 4% | – | New | Aug 5, 2025 |
| adjusted EBITDA marginnon-GAAP | FY2026 | 9.5% – 10.5% | – | New | Jan 24, 2025 |
| Implied adjusted EBITDA marginnon-GAAP | FY2026 | 10.6% | – | Raised | Oct 28, 2026 |
| sales | FY2030 | $10.00B | – | New | Feb 18, 2026 |
| adjusted EBITDA marginsnon-GAAP | FY2030 | 14% – 15% | – | New | Feb 18, 2026 |
| adjusted free cash flow marginsnon-GAAP | FY2030 | 6% | – | New | Feb 18, 2026 |
Guidance vs results
The last range DANA gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $7.30B – $7.50B | $8.12BΣ4Q | Above range |
Guidance history
Every forecast DANA put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | Adjusted EBITDA | FY2026 | $800.00M – $850.00M | New |
| Oct 28, 2026 | Diluted Adjusted EPS | FY2026 | $1.75 – $2.25 | New |
| Oct 28, 2026 | Adjusted free cash flow | FY2026 | $275.00M – $375.00M | New |
| Oct 28, 2026 | Implied adjusted EBITDA margin | FY2026 | 10.6% | Raised |
| Oct 28, 2026 | Sales | FY2026 | $7.75B – $7.85B | New |
| Apr 29, 2026 | Adjusted EBITDA | FY2026 | $750.00M – $850.00M | Reaffirmed |
| Apr 29, 2026 | Diluted Adjusted EPS | FY2026 | $2.00 – $3.00 | Reaffirmed |
| Apr 29, 2026 | Adjusted free cash flow | FY2026 | $250.00M – $350.00M | Reaffirmed |
| Apr 29, 2026 | Implied adjusted EBITDA margin | FY2026 | 10% – 11% | Reaffirmed |
| Apr 29, 2026 | Sales | FY2026 | $7.30B – $7.70B | Reaffirmed |
| Feb 18, 2026 | Adjusted EBITDA | FY2026 | $750.00M – $850.00M | New |
| Feb 18, 2026 | Diluted Adjusted EPS | FY2026 | $2.00 – $3.00 | New |
| Feb 18, 2026 | Adjusted free cash flow | FY2026 | $250.00M – $350.00M | New |
| Feb 18, 2026 | Implied adjusted EBITDA margin | FY2026 | 10% – 11% | Raised |
| Feb 18, 2026 | adjusted EBITDA margins | FY2030 | 14% – 15% | New |
| Feb 18, 2026 | adjusted free cash flow margins | FY2030 | 6% | New |
| Feb 18, 2026 | Sales | FY2026 | $7.30B – $7.70B | New |
| Feb 18, 2026 | sales | FY2030 | $10.00B | New |
| Oct 29, 2025 | Adjusted EBITDA | FY2025 | $570.00M – $610.00M | New |
| Oct 29, 2025 | Adjusted free cash flow | FY2025 | $250.00M – $300.00M | New |
| Oct 29, 2025 | Implied adjusted EBITDA margin | FY2025 | 7.8% – 8.1% | New |
| Oct 29, 2025 | fourth-quarter adjusted EBITDA margin | Q4 FY2025 | 10% – 10.5% | New |
| Oct 29, 2025 | Adjusted EBITDA margins | FY2026 | 10% – 10.5% | New |
| Oct 29, 2025 | Operating cash flow | FY2025 | $390.00M – $440.00M | New |
| Oct 29, 2025 | Sales | FY2025 | $7.30B – $7.50B | New |
| Aug 5, 2025 | Adjusted EBITDA | FY2025 | $540.00M – $610.00M | Lowered |
| Aug 5, 2025 | Adjusted free cash flow | FY2025 | $225.00M – $325.00M | Raised |
| Aug 5, 2025 | Adjusted free cash flow | FY2026 | 4% | New |
| Aug 5, 2025 | Implied adjusted EBITDA margin | FY2025 | 7.4% – 8.1% | New |
| Aug 5, 2025 | Adjusted EBITDA margins | FY2026 | 10% – 10.5% | New |
| Aug 5, 2025 | Operating cash flow | FY2025 | $550.00M – $650.00M | New |
| Aug 5, 2025 | Sales | FY2025 | $7.25B – $7.55B | Lowered |
| Apr 30, 2025 | Adjusted EBITDA | FY2025 | $925.00M – $1.03B | Reaffirmed |
| Apr 30, 2025 | Diluted Adjusted EPS | FY2025 | $1.15 – $1.65 | New |
| Apr 30, 2025 | Adjusted free cash flow | FY2025 | $175.00M – $275.00M | Reaffirmed |
| Apr 30, 2025 | Implied adjusted EBITDA | FY2025 | 9.7% – 10.2% | New |
| Apr 30, 2025 | Operating cash flow | FY2025 | $500.00M – $600.00M | New |
| Apr 30, 2025 | Sales | FY2025 | $9.53B – $10.03B | Reaffirmed |
| Jan 24, 2025 | net capital spend | FY2025 | $325.00M | New |
| Jan 24, 2025 | Adjusted EBITDA | FY2025 | $925.00M – $1.03B | New |
| Jan 24, 2025 | Free cash flow | FY2025 | $175.00M – $275.00M | New |
| Jan 24, 2025 | adjusted EBITDA margin | FY2026 | 9.5% – 10.5% | New |
| Jan 24, 2025 | Sales | FY2025 | $9.53B – $10.03B | New |
| Oct 30, 2024 | Adjusted EBITDA | FY2024 | $855.00M – $895.00M | Lowered |
| Oct 30, 2024 | Diluted Adjusted EPS | FY2024 | $0.75 – $0.95 | Lowered |
| Oct 30, 2024 | Diluted EPS | FY2024 | $0.05 – $0.25 | Lowered |
| Oct 30, 2024 | Free cash flow | FY2024 | $90.00M – $110.00M | Narrowed |
| Oct 30, 2024 | Operating cash flow | FY2024 | $465.00M – $485.00M | Lowered |
| Oct 30, 2024 | Sales | FY2024 | $10.20B – $10.40B | Lowered |
| Jul 31, 2024 | Adjusted EBITDA | FY2024 | $875.00M – $975.00M | Reaffirmed |
| Jul 31, 2024 | Diluted Adjusted EPS | FY2024 | $0.80 – $1.30 | Raised |
| Jul 31, 2024 | Diluted EPS | FY2024 | $0.35 – $0.85 | Reaffirmed |
| Jul 31, 2024 | Free cash flow | FY2024 | $75.00M – $125.00M | Raised |
| Jul 31, 2024 | Operating cash flow | FY2024 | $500.00M – $550.00M | Reaffirmed |
| Jul 31, 2024 | Sales | FY2024 | $10.45B – $10.95B | Lowered |
| Apr 30, 2024 | Adjusted EBITDA | FY2024 | $875.00M – $975.00M | Reaffirmed |
| Apr 30, 2024 | Diluted EPS | FY2024 | $0.35 – $0.85 | New |
| Apr 30, 2024 | Free cash flow | FY2024 | $50.00M – $100.00M | Raised |
| Apr 30, 2024 | Operating cash flow | FY2024 | $500.00M – $550.00M | New |
| Apr 30, 2024 | Sales | FY2024 | $10.65B – $11.15B | Reaffirmed |
| Feb 20, 2024 | Adjusted EBITDA | FY2024 | $875.00M – $975.00M | New |
| Feb 20, 2024 | Diluted EPS | FY2024 | $0.35 – $0.85 | New |
| Feb 20, 2024 | Free cash flow | FY2024 | $25.00M – $75.00M | New |
| Feb 20, 2024 | Operating cash flow | FY2024 | $475.00M – $525.00M | New |
| Feb 20, 2024 | Sales | FY2024 | $10.65B – $11.15B | New |
| Oct 27, 2023 | Adjusted EBITDA | FY2023 | $760.00M – $850.00M | Lowered |
| Oct 27, 2023 | Diluted adjusted EPS | FY2023 | $0.30 – $0.80 | Lowered |
| Oct 27, 2023 | Free cash flow | FY2023 | -$135.00M – -$20.00M | Lowered |
| Oct 27, 2023 | Operating cash flow | FY2023 | $375.00M – $490.00M | Lowered |
| Oct 27, 2023 | Sales | FY2023 | $10.20B – $10.70B | Lowered |
| Jul 28, 2023 | Adjusted EBITDA | FY2023 | $800.00M – $900.00M | Raised |
| Jul 28, 2023 | Diluted adjusted EPS | FY2023 | $0.65 – $1.05 | Raised |
| Jul 28, 2023 | Free cash flow | FY2023 | $50.00M – $100.00M | New |
| Jul 28, 2023 | Operating cash flow | FY2023 | $560.00M – $610.00M | Raised |
| Jul 28, 2023 | Sales | FY2023 | $10.45B – $10.95B | Raised |
| Apr 28, 2023 | Adjusted EBITDA | FY2023 | $750.00M – $850.00M | Reaffirmed |
| Apr 28, 2023 | Diluted adjusted EPS | FY2023 | $0.25 – $0.75 | Reaffirmed |
| Apr 28, 2023 | Operating cash flow | FY2023 | $510.00M – $560.00M | Reaffirmed |
| Apr 28, 2023 | Sales | FY2023 | $10.35B – $10.85B | Reaffirmed |
| Feb 21, 2023 | Adjusted EBITDA | FY2023 | $750.00M – $850.00M | New |
| Feb 21, 2023 | Diluted adjusted EPS | FY2023 | $0.25 – $0.75 | New |
| Feb 21, 2023 | Operating cash flow | FY2023 | $510.00M – $560.00M | New |
| Feb 21, 2023 | Sales | FY2023 | $10.35B – $10.85B | New |
| Oct 27, 2022 | Adjusted EBITDA | FY2022 | $700.00M – $740.00M | Reaffirmed |
| Oct 27, 2022 | Diluted adjusted EPS | FY2022 | $0.60 – $0.90 | Reaffirmed |
| Oct 27, 2022 | Free cash flow | FY2022 | 1.8% – 2.2% | Reaffirmed |
| Oct 27, 2022 | Operating cash flow | FY2022 | 6.2% – 6.5% | Reaffirmed |
| Oct 27, 2022 | Sales | FY2022 | $10.00B – $10.20B | Reaffirmed |
| Aug 3, 2022 | Adjusted EBITDA | FY2022 | $700.00M – $740.00M | Lowered |
| Aug 3, 2022 | Diluted adjusted EPS | FY2022 | $0.60 – $0.90 | Lowered |
| Aug 3, 2022 | Free cash flow | FY2022 | 1.8% – 2.2% | Lowered |
| Aug 3, 2022 | Operating cash flow | FY2022 | 6.2% – 6.5% | Raised |
| Aug 3, 2022 | Sales | FY2022 | $10.00B – $10.20B | Narrowed |
| Apr 27, 2022 | Adjusted EBITDA | FY2022 | $770.00M – $870.00M | New |
| Apr 27, 2022 | Diluted adjusted EPS | FY2022 | $1.05 – $1.55 | Lowered |
| Apr 27, 2022 | Free cash flow | FY2022 | 1.9% – 2.3% | Lowered |
| Apr 27, 2022 | Operating cash flow | FY2022 | 5.9% – 6.5% | Lowered |
| Apr 27, 2022 | Sales | FY2022 | $9.85B – $10.35B | Raised |
| Feb 23, 2022 | Diluted adjusted EPS | FY2022 | $2.05 – $2.55 | New |
| Feb 23, 2022 | Free cash flow | FY2022 | 2.5% – 3.5% | New |
| Feb 23, 2022 | Operating cash flow | FY2022 | 6.5% – 7.5% | New |
| Feb 23, 2022 | Sales | FY2022 | $9.60B – $10.10B | New |
| Oct 26, 2021 | Adjusted EBITDA | FY2021 | $815.00M – $875.00M | New |
| Oct 26, 2021 | Diluted adjusted EPS | FY2021 | $1.65 – $2.05 | New |
| Oct 26, 2021 | Free cash flow | FY2021 | 1% | New |
| Oct 26, 2021 | Operating cash flow | FY2021 | 5% | New |
| Oct 26, 2021 | implied adjusted EBITDA margin | FY2021 | 9.5% | New |
| Oct 26, 2021 | Sales | FY2021 | $8.80B – $9.00B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases DANA filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Results
- Results
- Update
- Results
- Update
- Update
- Update
- Update
- Results
- Update
- Results
See a number that looks wrong?